Ashland (NYSE:ASH) Releases Earnings Results

Ashland (NYSE:ASH) posted its quarterly earnings results on Wednesday. The basic materials company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.28 by ($0.02), Briefing.com reports. The business had revenue of $522.00 million for the quarter, compared to the consensus estimate of $524.07 million. Ashland had a return on equity of 5.98% and a net margin of 7.01%. Ashland’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.41 earnings per share. Ashland updated its FY 2025 guidance to EPS.

Ashland Stock Up 1.1 %

NYSE ASH traded up $0.88 on Friday, reaching $81.58. The company had a trading volume of 168,416 shares, compared to its average volume of 418,290. The stock has a market capitalization of $3.98 billion, a P/E ratio of 27.54, a P/E/G ratio of 1.14 and a beta of 0.88. The company’s fifty day moving average is $86.13 and its 200 day moving average is $91.66. Ashland has a 52-week low of $71.55 and a 52-week high of $102.50. The company has a quick ratio of 1.84, a current ratio of 2.98 and a debt-to-equity ratio of 0.45.

Analyst Ratings Changes

A number of equities analysts have issued reports on ASH shares. StockNews.com cut Ashland from a “buy” rating to a “hold” rating in a report on Friday, September 13th. JPMorgan Chase & Co. raised Ashland from an “underweight” rating to a “neutral” rating and lowered their target price for the stock from $90.00 to $89.00 in a research report on Thursday, August 8th. UBS Group lowered their target price on Ashland from $116.00 to $107.00 and set a “buy” rating on the stock in a research report on Thursday, August 15th. BMO Capital Markets lowered their target price on Ashland from $105.00 to $92.00 and set a “market perform” rating on the stock in a research report on Friday, August 9th. Finally, Wells Fargo & Company lowered their target price on Ashland from $112.00 to $100.00 and set an “overweight” rating on the stock in a research report on Thursday, August 8th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $103.50.

Ashland Company Profile

Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.